18 research outputs found
Castrate Testosterone Predicts Biochemical Relapse Free Survival In Non-Metastatic Prostate Cancer
Wo
Metastases Directed Sbrt Using Ga68-Psma For Oligometastatic Prostate Cancer: Trod 09-002 Study
Wo
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al.
The Role Of (68)Ga-Psma-Pet/Ct In Pelvic Field Delineation In Prostate Cancer Patients With Pelvic Lymph Node Metastasis
Wo
Clinical Outcomes for Patients with Gleason Score 10 Prostate Adenocarcinoma: TROD 09-004 Study
38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) -- APR 26-30, 2019 -- Milan, ITALYWOS: 000468315604108European Soc Radiotherapy & Onco